The vast majority of dermatologists around the world—95.6 percent—believe climate change is occurring, and 88 percent think it will impact the incidence of skin diseases, according to the first international survey of dermatologists on the topic, conducted online by the International Society of Dermatology's Climate Change Committee. FDA has approved MC2 Therapeutics Wynzora Cream for once-daily topical treatment of plaque psoriasis in adults. Tremfya is the first IL-23 inhibitor FDA-approved for active psoriatic arthritis. AbbVie's upadacitinib met both primary and all secondary endpoints in Measure Up 2, the second Phase 3 study in individuals with moderate to severe atopic dermatitis.
SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients ages 6 to under 18. LEO Pharma’s Finacea Foam (azelaic acid 15%) is back in pharmacies—just in time for Rosacea Awareness Month.
In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of psoriasis.
With more experience using IL-23 inhibitors to treat psoriasis, dermatologists are seeing high levels of patient satisfaction and no new safety signals. Jennifer Cather, MD assesses the clinical experience.
Early Study Demonstrates Roflumilast cream Safe and Effective for Chronic Plaque Psoriasis
New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types
New York’s Mount Sinai Health System Names New Chair of Dermatology and New Dean For Clinical Therapeutics
DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates
Mount Sinai Researcher Identifies Single Gene Biomarker to Differentiate Between Atopic Dermatitis and Psoriasis
Ask Dr. Friedman
Not many topical formulations tout benefits for psoriasis, but that doesn't mean there are no useful products. Dr. Friedman offers his take.
Adam Friedman, MD, FAAD